The FDA approved pembrolizumab in combination with paclitaxel, with or without bevacizumab, for adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma whose tumors express PD-L1 (CPS ≥1).
The FDA approved pembrolizumab (Keytruda) and Keytruda Qlex plus paclitaxel, with or without bevacizumab, for adults with PD-L1+ platinum-resistant ovarian carcinoma based on Phase 3 trial data showing improved survival outcomes.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07435922 |
Evaluate Recombinant Human Serum Albumin From Oryza Sativa In Patients With Hypoalbuminemia and/or Hypovolemia Requiring Urgent Treatment |
NOT_YET_RECRUITING | |
| NCT07186478 |
I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis |
ACTIVE_NOT_RECRUITING | NA |
| NCT07116239 |
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome |
NOT_YET_RECRUITING | NA |
| NCT06998030 |
Silent Threat: Impact of Preoperative Albumin Levels on Outcomes in Geriatric Cancer Surgery |
COMPLETED | |
| NCT06961825 |
Brief Title: The Role of Nutrition in the Rehabilitation of Patients With Eating Disorders After a Vascular Stroke. |
NOT_YET_RECRUITING | NA |
| NCT06792448 |
Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study |
NOT_YET_RECRUITING | |
| NCT06681415 |
Efficacy of 20% Human Albumin in Reducing Pleural Effusion After Cardiopulmonary Bypass |
COMPLETED | PHASE4 |
| NCT06563089 |
Hypoalbuminemia in Critically Sick Children |
NOT_YET_RECRUITING | |
| NCT06355479 |
A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia |
COMPLETED | PHASE3 |
| NCT05797649 |
Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study) |
RECRUITING |
